What 8 Analyst Ratings Have To Say About Exact Sciences
Portfolio Pulse from Benzinga Insights
In the last quarter, 8 analysts provided ratings for Exact Sciences (NASDAQ:EXAS), with 5 being bullish, 1 somewhat bullish, and 2 indifferent. The average price target is $87.25, slightly below the current price of $87.29. The average price target has increased by 16.78% over the past month.
June 07, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Exact Sciences (NASDAQ:EXAS) received 5 bullish, 1 somewhat bullish, and 2 indifferent ratings from 8 analysts in the last quarter. The average price target is $87.25, slightly below the current price of $87.29.
The average price target for Exact Sciences is slightly below the current price, indicating a potential downside. However, the majority of analysts have a bullish or somewhat bullish outlook, which could balance the short-term impact on the stock price. The 16.78% increase in the average price target over the past month also suggests a positive sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100